Project 4: Berto
Project 4: Berto
批准号:
10556545
负责人:
Stefano Berto
金额:
$22.65万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2028-02-29
关键词:
AffectAgeAllelesAnimal ModelAnimalsAttention deficit hyperactivity disorderBehaviorBehavioralBioinformaticsBiological ModelsBiological ProcessBrainCRISPR/Cas technologyCell Adhesion MoleculesCell modelCenters of Research ExcellenceChildCognitionDataDevelopmentDiseaseElectroencephalographyElectrophysiology (science)EnvironmentEpilepsyEpisodic memoryFaceFamilyFrequenciesFutureGenerationsGenesGenetic TranscriptionGenomicsHLA AntigensHumanImageImpaired cognitionIntellectual functioning disabilityInterleukin ReceptorInterleukin-1InvestigationKnockout MiceLinkMeasuresMemoryMessenger RNAMissionMolecularMutationNeuroanatomyNeurodevelopmental DisorderNeuronsPTPRR genePatternPhenotypePlayProtein Tyrosine PhosphatasePublishingRegulationResearch PersonnelResourcesRiskRoleShort-Term MemorySignal PathwaySynapsesSynaptic TransmissionSynaptic plasticityTestingUnited StatesUnited States National Institutes of HealthVertebral columnVisualautism spectrum disorderbehavioral phenotypingcareer developmentdensitydisorder riskexcitatory neuronhearing impairmenthuman subjectinduced pluripotent stem cellinnovationloss of functionloss of function mutationmotor impairmentmouse modelmultidisciplinaryneurodevelopmentneuronal excitabilityneurotransmitter releasenovelparalogous geneprogramsreceptorrisk variantsingle nucleus RNA-sequencingsocialsynaptic functionsynaptogenesistranscriptomics
中文摘要
项目4 -概要
神经发育障碍(NDD)是由分子和突触发育异常引起的。
大脑中的网络,其特征是发育行为缺陷,具有明显的社会和认知功能,
损伤在美国,大约15%的3至17岁的儿童受到NDD的影响,
包括自闭症谱系障碍(ASD)、注意力缺陷多动障碍(ADHD)、癫痫、智力障碍
残疾(ID)、听力障碍、视觉/运动障碍等。有趣的是,
ASD和ID也以许多与记忆相关的缺陷为标志,例如面部身份识别,工作
记忆和情景记忆然而,基因,记忆表型和NDD之间的联系很差
明白该项目的重点是NDD风险基因IL 1 RAPL 2在人类iPSC衍生的细胞中的功能。
兴奋性神经元和ASD样和记忆行为使用一个新开发的小鼠模型。我们
假设IL 1 RAPL 2在神经发育障碍和记忆表型中起关键作用,
调节皮层兴奋性神经元的突触发育。目标1将利用人类IPSC-
IL 1 RAPL 2功能丧失(LoF)的深层兴奋性神经元,以了解其在
转录组学景观,调节树突状分支和棘密度,以及神经元兴奋性
和突触传递。Aim 2将利用具有全局Il 1 rap 12 LoF的新小鼠模型来模拟
人类中的LoF突变,这将使人们能够理解它在NDD和记忆相关行为中的作用。
NIH COBRE神经发育及其障碍(CNDD)将提供一个理想的环境,
资源和核心,以及职业发展机会,使博士贝尔托成功过渡到
MUSC的独立调查员此外,拟议的研究和采用的方法,
这些数据对国家民主与发展委员会的使命和主题都很重要,而且高度相关。
Berto,用于未来的竞争R 01应用。
英文摘要
PROJECT 4 – SUMMARY
Neurodevelopmental disorders (NDDs) are caused by abnormal development of molecular and synaptic
networks in the brain and are characterized by developmental behavioral deficits with clear social and cognitive
impairments. Approximately 15% of children in the United States ages 3 to 17 years are affected by NDDs which
include autism spectrum disorders (ASD), attention-deficit hyperactivity disorder (ADHD), epilepsy, intellectual
disability (ID), hearing impairments, visual/motor impairments, among others. Interestingly, NDDs, in particular
ASD and ID, are also marked by a number of memory-related deficits, such as face identity recognition, working
memory, and episodic memory. Nevertheless, the link between genes, memory phenotypes, and NDDs is poorly
understood. This project focuses on the function of the NDD risk gene, IL1RAPL2, in human iPSC-derived
excitatory neurons and in ASD-like and memory behaviors using a newly developed mouse model. We
hypothesize that IL1RAPL2 plays a key role in neurodevelopmental disorders and memory phenotypes by
regulating synapse development on cortical excitatory neurons. Aim 1 will take advantage of human IPSC-
derived deep layer excitatory neurons with IL1RAPL2 loss-of-function (LoF) to understand its function in the
transcriptomic landscapes, in regulation of dendritic arborization and spine density, and in neuronal excitability
and synaptic transmission. Aim 2 will take advantage of a new mouse model with a global Il1rapl2 LoF to mimic
LoF mutations in humans, that will enable an understanding of its role in NDDs and memory related behaviors.
The NIH COBRE in Neurodevelopment and Its Disorders (CNDD) will provide an ideal environment, critical
resources and Cores, and career development opportunities to enable the successful transition of Dr. Berto to
an established, independent investigator at MUSC. Moreover, the proposed studies, and approaches employed,
are important and highly relevant to the mission and theme of the CNDD, and the Project data will prepare Dr.
Berto for a future competitive R01 application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: